Clinical Trials on Chronic Phase of Disease
Total 50340 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous LeukemiaUnited States
-
Hamad Medical CorporationTerminatedChronic Myeloid Leukemia - Chronic PhaseQatar
-
Arbeitsgemeinschaft medikamentoese TumortherapieAOP Orphan Pharmaceuticals AGCompletedChronic Phase Chronic Myeloid LeukemiaAustria
-
University of Michigan Rogel Cancer CenterTerminatedChronic Myeloid LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
Ariad PharmaceuticalsTerminatedChronic Phase Chronic Myeloid LeukemiaBelgium
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedChronic Phase Chronic Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
M.D. Anderson Cancer CenterCompleted
-
University of Michigan Rogel Cancer CenterNovartisWithdrawnChronic Myeloid LeukemiaUnited States
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
M.D. Anderson Cancer CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedLeukemia, Myeloid, ChronicUnited States
-
PETHEMA FoundationCompleted
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Rex Cancer Center, Raleigh, NCNorthwestern UniversityTerminatedChronic Phase CMLUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Hospices Civils de LyonUnknown
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase...United States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruiting
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of MunichActive, not recruiting
-
Hybrigenics CorporationUnknown
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Disease | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Accelerated Phase of Disease | Chronic Phase of DiseaseUnited States
-
Bristol-Myers SquibbWithdrawnMyeloid Leukemia, Chronic, Chronic-PhaseUnited States
-
Bristol-Myers SquibbCompletedLeukemia, Myeloid, Chronic-Phase (CML-CP)
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, Chronic PhaseUnited States, Argentina, Italy, Canada, Australia, Brazil
-
Poitiers University HospitalCompletedChronic Phase of Chronic Myeloid Leukemia
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia, Myelogenous, ChronicUnited States
-
Emory UniversityTerminatedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
Kanto CML Study GroupUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Myelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Seoul St. Mary's HospitalBristol-Myers SquibbRecruitingChronic Myelocytic LeukemiaKorea, Republic of
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
Onco Medical Consult GmbHCompletedTreating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib (DasPAQT)Myeloid Leukemia, Chronic, Chronic-PhaseGermany
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Novartis PharmaceuticalsRecruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Assiut UniversityNot yet recruiting
-
Ascentage Pharma Group Inc.Not yet recruitingChronic Myeloid Leukemia | CML | CML, Chronic PhaseUnited States
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Hikma Pharmaceuticals LLCCompletedChronic Myelogenous LeukemiaJordan, Lebanon, Saudi Arabia, Tunisia
-
Associazione Italiana Pazienti Leucemia Mieloide...Not yet recruitingChronic Myeloid Leukemia (CML)Italy
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingValidity and SafetyChina